Methylphenidate-Induced Akathisia in a Patient With Multiple Sclerosis
Prim Care Companion J Clin Psychiatry 2006;8(6):379-380 [letter]
© Copyright 2016 Physicians Postgraduate Press, Inc.
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Sir: Methylphenidate is a short-acting psychostimulant that
is structurally and pharmacologically similar to dextroamphetamine
and is primarily used in the treatment of attention-deficit/
hyperactivity disorder (ADHD).1,2 Its use has also been explored
for the treatment of apathy and for augmentation of
effects of antidepressants.3 It acts as a dopaminergic and noradrenergic